Correlates of risky injection practices among past-year injection drug users among the US general population

Drug and Alcohol Dependence

Volumn 116, Issue 1-3, 2011, Pages 64-71

  Ropelewski, Lauren R ^a   Mancha, Brent E ^a   Hulbert, Alicia ^b   Rudolph, Abby E ^a   Martins, Silvia S ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV risk behaviors; Injection drug users; Injection risk behaviors; NSDUH

Indexed keywords

BLEACHING AGENT; COCAINE; DIAMORPHINE; METHAMPHETAMINE;

ADULT; ARTICLE; CLEANING; DISEASE TRANSMISSION; HARM REDUCTION; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; INTRAVENOUS DRUG ABUSE; NEEDLE; PRIORITY JOURNAL; UNITED STATES;

ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; CRACK COCAINE; DATABASES, FACTUAL; DRUG USERS; FEMALE; HUMANS; MALE; NEEDLE SHARING; NEEDLES; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 79957615105     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.11.025     Document Type: Article

References (61)

1. Anthony J.C., Vlahov D., Nelson K.E., Cohn S., Astemborski J., Solomon L. New evidence on intravenous cocaine use and the risk of infection with Human Immunodeficiency Virus Type 1. Am. J. Epidemiol. 1991, 134:1175-1189.
2. Bennett G.A., Velleman R.D., Barter G., Bradbury C. Gender differences in sharing injecting equipment by drug users in England. AIDS Care 2000, 12:77-87.
3. Blankenship K.M., Smoyer A.B., Bray S.J., Mattocks K. Black-white disparities in HIV/AIDS: the role of drug policy and the correction system. J. Health Care Poor Underserved. 2005, 16(4 Suppl. B):140-156.
4. Booth R.E., Watters J.K., Chitwood D.D. HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am. J. Public Health 1993, 83:1144-1148.
5. Burt R.D., Hagan H., Garfein R.S., Sabin K., Weinbaum C., Thiede H. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventative measures among Seattle injection drug users aged 18-30 years, 1994-2004. J. Urban Health 2007, 84:436-454.
6. Burt R.D., Hagan H., Sabin K., Thiede H. Evaluating respondent-driven sampling in a major metropolitan area: comparing injection drug users in the 2005 Seattle area National HIV Behavioral Surveillance System Survey with participants in the RAVEN and Kiwi studies. Ann. Epidemiol. 2010, 20:159-167.
7. Bux D.A., Lamb R.J., Iguchi M.Y. Cocaine use and HIV risk behavior in methadone maintenance patients. Drug Alcohol Depend. 1995, 37:29-35.
8. Centers for Disease Control and Prevention, 1987. MMWR weekly: Human Immunodeficiency Virus Infection in the United States- A Review of Current Knowledge. Available at: (accessed on January 6, 2010). http://www.cdc.gov/mmwR/preview/mmwrhtml/00014715.htm.
9. Centers for Disease Control and Prevention, 2001a. MMWR weekly: Public Health and Injection Drug Use. Available at: (accessed on December 28, 2009). http://www.cdc.gov/mmwr/pdf/wk/mm5019.pdf.
10. Centers for Disease Control and Prevention, 2001b. MMWR weekly: Soft Tissue Infections Among Injection Drug Users --- San Francisco, California, 1996-2000. Available at: (accessed on March 5, 2010). http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5019a3.htm.
11. Centers for Disease Control and Prevention, 2002a. Fact Sheet: Drug Associated HIV Transmission Continues in the United States. Available at: (accessed on December 30, 2009). http://www.cdc.gov/hiv/resources/factsheets/idu.htm.
12. Centers for Disease Control and Prevention, 2002b. IDU HIV Prevention: Viral Hepatitis and Injection Drug Users. Available at: (accessed on March 10, 2010). http://www.cdc.gov/idu/hepatitis/viral_hep_drug_use.pdf.
13. Centers for Diseaes Control and Prevention, 2005. HIV/AIDS Fact Sheet: Coinfection with HIV and Hepatitis C Virus. Available at: (accessed on March 5, 2010). http://www.cdc.gov/hiv/resources/factsheets/PDF/coinfection.pdf.
14. Centers for Disease Control and Prevention, 2008. Fact Sheet: Estimates of New HIV Infections in the United States. Available at: (accessed on March 3, 2010). http://www.cdc.gov/hiv/topics/surveillance/resources/factsheets/pdf/incidence.pdf.
15. Centers for Disease Control and Prevention, 2009. MMWR weekly: HIV-Associated Behaviors Among Injecting-Drug Users-23 Cities, United States, May 2005-February 2006 (Revised). Available at: (accessed on December 28, 2009). http://www.cdc.gov/hiv/resources/reports/mmwr/mm5813_err.htm.
16. Centers for Disease Control and Prevention, 2010. Fact Sheet: HIV and AIDS in the United States. Available at: (accessed on August 27, 2010). http://www.cdc.gov/hiv/resources/factsheets/PDF/us.pdf.
17. Cherubin C.E. The medical sequelae of narcotic addiction. Ann. Intern. Med. 1967, 67:23-33.
18. Des Jarlais D.C., Arasteh K., McKnight C., Hagan H., Perlman D., Friedman S.R. Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City. Drug Alcohol Depend. 2009, 101:88-91.
19. Des Jarlais D.C., Arasteh K., Perlis T., Hagan H., Abdul-Quader A., Heckathorn D.D., McKnight C., Bramson H., Nemeth C., Torian L.V., Friedman S.R. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS 2007, 21:231-235.
20. Des Jarlais D.C., Perlis T., Friedman S.R., Chapman T., Kwok J., Rockwell R., Paone D., Millken J., Monterroso E. Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City 1990-1997. Am. J. Public Health 2000, 90:1112-1116.
21. Evans J.L., Hahn J.A., Page-Shafer K., Lum P.J., Stein E.S., Davidson P.J., Moss A.R. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J. Urban Health 2003, 80:137-146.
22. Frajzyngier V., Neaigus A., Gyarmathy V.A., Miller M., Friedman S.R. Gender differences in injection risk behaviors at the first injection episode. Drug Alcohol Depend. 2007, 89:145-152.
23. Gibbs D.A., Hamill D.N., Magruder-Habib K. Populations at increased risk of HIV infection: current knowledge and limitations. J. Acquir. Immune Defic. Syndr. 1991, 4:881-889.
24. Golub E.T., Bareta J.C., Mehta S.H., McCall L.D., Vlahov D., Strathdee S.S. Correlates of unsafe syringe acquisition and disposal among injection drug users in Baltimore, MD. Subst. Use Misuse 2005, 40:1751-1764.
25. Hagan H., Des Jarlais D.C. HIV and HCV infection among injecting drug users. Mt. Sinai J. Med. 2000, 67:423-428.
26. Hahn J.A., Page-Shafer K., Lum P.J., Bourgois P., Stein E., Evans J.L., Busch M.P., Tobler L.H., Phelps B., Moss A.R. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J. Infect. Dis. 2002, 186:1558-1564.
27. Homann C., Krogsgaard K., Pedersen C., Andersson P., Nielsen J.O. High incidence of hepatitis B infection and evolution of chronic hepatitis B infection in patients with advanced HIV infection. J. Acquir. Immune Defic. Syndr. 1991, 4:416-420.
28. Hudgins R., McCusker J., Stoddard A. Cocaine use and risky injection and sexual behaviors. Drug Alcohol Depend. 1995, 37:7-14.
29. Huo D., Oullet L.J. Needle exchange and injection-related risk behaviors in Chicago. J. Acquir. Immune Defic. Syndr. 2007, 45:108-114.
30. Joe G.W., Simpson D.D. HIV risks, gender, and cocaine use among opiate users. Drug Alcohol Depend. 1995, 37:23-28.
31. Kral A.H., Bluthenthal R.N., Lorvick J., Gee L., Bacchetti P., Edlin B.R. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 2001, 357:1397-1401.
32. Kral, A.H., Malekinejad, M., Vaudrey, J., Martinez, A.N., Lorvick, J., McFarland, W., Raymond H.F., 2010. Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco. J. Urban Health (Online early articles. Published online on 26 June 2010).
33. Latkin C.A., Forman V.L. Patterns of needle acquisition and sociobehavioral correlates of needle exchange program attendance in Baltimore, Maryland, USA. J. Acquir. Immune Defic. Syndr. 2001, 27:398-404.
34. Latkin C.A., Kuramoto S.J., Davey-Rothwell M.A., Tobin K.E. Social norms, social networks, and HIV risk behavior among injection drug users. AIDS Behav. 2009, (Online early articles. Published online on 23 May 2009).
35. Louria D.B., Hensle T., Rose J. The major medical complications of heroin addiction. Ann. Intern. Med. 1967, 67:1-22.
36. Macalino G.E., Celentano D.D., Latkin C., Strathdee S.A., Vlahov D. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ. Prev. 2002, 14:367-378.
37. Magura S., Grossman J.I., Lipton D.S., Siddiqi Q., Shapiro J., Marion I., Amann K.R. Determinants of needle sharing among intravenous drug users. Am. J. Public Health 1989, 79:459-462.
38. Mandell W., Vlahov D., Latkin C., Oziemkowska M., Cohn S. Correlates of needle sharing among injection drug users. Am. J. Public Health 1994, 84:920-923.
39. McCoy C.B., Lai S., Metsch L.R., Messiah S.E., Zhao W. Injection drug use and crack cocaine smoking: independent and dual risk behaviors for HIV infection. Ann. Epidemiol. 2004, 14:535-542.
40. Mehta S., Galai N., Astemborski J., Celentano D.D., Strathdee S.A., Vlahov D., Nelson K.E. HIV incidence among injection drug users in Baltimore, Maryland (1994-2004). J. Acquir. Immune Defic. Syndr. 2006, 43:368-372.
41. Mitchell M.M., Latimer W.W. Gender differences in high risk sexual behaviors and injection practices associated with perceived HIV risk among injection drug users. AIDS Educ. Prev. 2009, 21:384-394.
42. Molitor F., Ruiz J.D., Flynn N., Mikanda J.N., Sun R.K., Anderson R. Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. Am. J. Drug Alcohol Abuse 1999, 25:475-493.
43. Montgomery S.B., Hyde J., Johnson De Rosa C., Rohrbach L.A., Ennett S., Harvey S.M., Clatts M., Iverson E., Kipke M.D. Gender differences in HIV risk behaviors among young injectors and their social network members. Am. J. Drug Alcohol Abuse 2002, 28:453-475.
44. Moss A.R., Vranizan K., Gorter R., Bacchetti P., Watters J., Osmond D. HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS 1994, 8:223-231.
45. National Institute on Drug Abuse, 2008. Research report series- methamphetamine abuse and addiction. Available at: (accessed on April 30, 2010). http://www.drugabuse.gov/Researchreports/Methamph/methamph3.html.
46. Nelson K.E., Galai N., Safaeian M., Strathdee S.A., Celentano D.D., Vlahov D. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. Am. J. Epidemiol. 2002, 156:641-653.
47. Office of Management and Budget, 2000. Standards for defining metropolitan and micropolitan statistical areas; notice. Available at: (accessed on March 3, 2010). http://www.census.gov/population/www/metroareas/files/00-32997.pdf.
48. QuIHN Ltd., 2010. Reusing needles and sharing gear. Available at: (accessed on January 13, 2010). http://www.saferinjecting.net/injecting-sharing-gear.htm.
49. Robinson W.T., Risser J.M.H., McGoy S., Becker A.B., Rehman H., Jefferson M., Griffin V., Wolverton M., Tortu S. Recruiting injection drug users: a three-site comparison of results and experiences with respondent-driven and targeted sampling procedures. J. Urban Health 2006, 83:i29-i38.
50. Roy E., Boudreau J.F., Leclerc P., Boivin J.F., Godin G. Trends in injection drug use behaviors over 10 years among street youth. Drug Alcohol Depend. 2007, 89:170-175.
51. Rudolph, A.E., Crawford, N.D., Latkin, C., Heimer, R., Benjamin, E.O., Jones, K.C., Fuller, C.M., 2011. Sub-populations of illicit drug users reached by targeted street outreach and respondent driven sampling strategies: implications for research and public health practice. Ann. Epidemiol.
52. Rudolph A.E., Crawford N.D., Ompad D.C., Benjamin E.O., Stern R.J., Fuller C.M. Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies. J. Am. Pharm. Assoc. 2010, 50:140-147.
53. Sherman K.E., Rouster S.D., Chung R.T., Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US Adult AIDS Clinical Trials Group. Clin. Infect. Dis. 2002, 34:831-837.
54. Solomon L., Astemborski J., Warren D., Muñoz A., Cohn S., Vlahov D., Nelson K.E. Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users. Am. J. Epidemiol. 1993, 137:892-898.
55. StataCorp, 2007. Stata Statistical Software: Release 10.0. Stata Corporation, College Station, TX.
56. Strathdee S.A., Sherman S.G. The role of sexual transmission of HIV infection among injection and non-injection drug users. J. Urban Health 2003, 80(Suppl. 3):iii7-iii14.
57. Substance Abuse and Mental Health Services Administration, 2006. Results from the 2005 National Survey on Drug Use and Health: National Findings. NSDUH Series H-30, DHHS Publication No. SMA 06-4194. Office of Applied Studies, Rockville, MD.
58. Substance Abuse and Mental Health Services Administration, 2007. Results from the 2006 National Survey on Drug Use and Health: National Findings. NSDUH Series H-32, DHHS Publication No. SMA 07-4293. Office of Applied Studies, Rockville, MD.
59. Substance Abuse and Mental Health Services Administration, 2008. Results from the 2007 National Survey on Drug Use and Health: National Findings. NSDUH Series H-34, DHHS Publication No. SMA 08-4343. Office of Applied Studies, Rockville, MD.
60. Substance Abuse and Mental Health Services Administration, 2009. Results from the 2008 National Survey on Drug Use and Health: National Findings. NSDUH Series H-36, HHS Publication No. SMA 09-4434. Office of Applied Studies, Rockville, MD.
61. Thorpe L.E., Bailey S.L., Huo D., Monterroso E.R., Ouellet L.J. Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997-1999). J Acquir. Immune Defic. Syndr. 2001, 27:71-78.